RPA
EVH icon

Rock Point Advisors’s Evolent Health EVH Stock Holding History

Rock Point Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.32M Sell
1,719,886
-66,795
-4% -$256K 2.28% 13
2026
Q1 		$4.07M Buy
1,786,681
+596,525
+50% +$1.89M 1.1% 37
2025
Q4 		$4.76M Buy
1,190,156
+211,707
+22% +$1.18M 1.19% 36
2025
Q3 		$8.28M Buy
978,449
+128,489
+15% +$1.25M 2.19% 16
2025
Q2 		$9.57M Buy
849,960
+25,425
+3% +$234K 2.7% 10
2025
Q1 		$7.81M Buy
824,535
+225,396
+38% +$2.28M 2.41% 13
2024
Q4 		$6.74M Buy
599,139
+133,357
+29% +$2.34M 1.96% 19
2024
Q3 		$13.2M Sell
465,782
-26,605
-5% -$686K 3.6% 6
2024
Q2 		$9.41M Buy
492,387
+140,780
+40% +$3.6M 2.82% 10
2024
Q1 		$11.5M Sell
351,607
-31,904
-8% -$1.02M 3.42% 5
2023
Q4 		$12.7M Buy
383,511
+8,240
+2% +$233K 3.84% 5
2023
Q3 		$10.2M Buy
375,271
+44,823
+14% +$1.25M 3.54% 5
2023
Q2 		$10M Sell
330,448
-21,359
-6% -$691K 3.29% 7
2023
Q1 		$11.4M Sell
351,807
-3,544
-1% -$112K 3.88% 3
2022
Q4 		$9.98M Buy
355,351
+30,510
+9% +$875K 3.45% 6
2022
Q3 		$11.7M Sell
324,841
-8,800
-3% -$310K 4.34% 3
2022
Q2 		$10.2M Sell
333,641
-57,973
-15% -$1.69M 3.5% 4
2022
Q1 		$12.6M Buy
391,614
+2,535
+0.7% +$66.4K 3.77% 3
2021
Q4 		$10.8M Sell
389,079
-26,011
-6% -$746K 3.03% 7
2021
Q3 		$12.9M Sell
415,090
-69,875
-14% -$1.68M 3.77% 4
2021
Q2 		$10.2M Buy
484,965
+55
+0% +$1.1K 2.95% 8
2021
Q1 		$9.79M Sell
484,910
-46,795
-9% -$890K 3.05% 8
2020
Q4 		$8.52M Sell
531,705
-29,789
-5% -$394K 2.93% 12
2020
Q3 		$6.97M Sell
561,494
-106,699
-16% -$1.25M 3.09% 13
2020
Q2 		$4.76M Sell
668,193
-79,120
-11% -$530K 2.22% 14
2020
Q1 		$4.06M Buy
747,313
+214,815
+40% +$1.92M 2.41% 16
2019
Q4 		$4.82M Sell
532,498
-93,217
-15% -$757K 1.96% 20
2019
Q3 		$4.5M Buy
625,715
+191,230
+44% +$1.37M 2.03% 21
2019
Q2 		$3.45M Buy
434,485
+191,455
+79% +$2.27M 1.57% 27
2019
Q1 		$3.06M Buy
+243,030
New +$3.85M 1.44% 29

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rock Point Advisors's EVH Position: Q2 2026 in Review

Rock Point Advisors reduced its Evolent Health (EVH) stake by 3.7% in Q2 2026, selling an estimated $256K and leaving 1,719,886 shares worth $9.32M. The position accounts for 2.28% of the portfolio, ranked #13.

Rock Point Advisors first reported a position in EVH in Q1 2019 and has held it in 30 quarters since. The position peaked at $13.2M in Q3 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Rock Point Advisors held 1,719,886 shares of Evolent Health worth $9.32M as of Q2 2026.
  • Rock Point Advisors sold 66,795 Evolent Health shares in Q2 2026, an estimated $256K.
  • Evolent Health made up 2.28% of Rock Point Advisors's portfolio in Q2 2026, its #13 holding.
  • Rock Point Advisors first reported a position in Evolent Health in Q1 2019 and has held it in 30 quarters since.
  • Rock Point Advisors's Evolent Health position peaked at $13.2M in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Rock Point Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.